Discussion on the rationality of adopting the form of equity pricing to trade the patent of service invention in public hospitals

张敏,支闻沁,程蕾蕾

DOI: https://doi.org/10.3760/cma.j.cn113565-20200308-00081

2020-01-01

Abstract:Objective:Patent is one of the most common carriers of medical research innovation. The development of translational medicine is the general trend. It is necessary to explore patent transformation using multiple transactions in public hospitals. This study focused on whether it is appropriate for public hospitals to transfer scientific achievements by equity valuation.Methods:To study the transformation of scientific achievements of state-owned intangible assets in China, summarize the common transaction methods of scientific achievements in colleges, universities as well as scientific research institutions according to literature review and policy analysis, combined with the state-owned hospital’s asset management measures.Results:Through comparative analysis of the differences among public hospitals, universities and scientific research institutions, taking into consideration of the regulations on intangible assets management of hospitals, it is confirmed that public hospitals are not suitable for the transformation of scientific achievements by the way of equity pricing in current. However, other patent transfer and patent license methods are feasible, which can effectively promote the development of translational medicine alternatively.Conclusions:In view of the particularity of public hospitals, public hospitals need to explore multiple transactions to suit for the transformation of hospital patents. Although the current stage of equity pricing transfer does not conform to the asset management regulations of public hospitals, there are other ways to choose at this stage.